# Kalehua Capital Management LLC: Form 13F holdings

An institutional investment manager in DALLAS, TX. SEC CIK 2106181.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $139.5m
- Positions: 49 (23 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2106181/000210618126000007/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| EA SERIES TRUST | ALPHA ARCH 1-3 | $26.5m | 8.4% | 226,188 |  | Added +107,766 |
| [Veradermics Inc (MANE)](/companies/mane.md) | COMMON STOCK | $17.9m | 5.7% | 145,695 |  | Added +42,816 |
| [Veradermics Inc (MANE)](/companies/mane.md) | COOMON STOCK | $17.9m | 5.7% | 145,695 |  | Added +42,816 |
| [X4 Pharmaceuticals Inc (XFOR)](/companies/xfor.md) | COM NEW | $17.4m | 5.5% | 3,722,840 |  | Unchanged |
| [X4 Pharmaceuticals Inc (XFOR)](/companies/xfor.md) | COM NEW | $17.4m | 5.5% | 3,722,840 |  | Unchanged |
| [Compass Pathways Plc (CMPS)](/companies/cmps.md) | SPONSORED ADS | $11.6m | 3.7% | 819,692 |  | Unchanged |
| [Compass Pathways Plc (CMPS)](/companies/cmps.md) | SPONSORED ADS | $11.6m | 3.7% | 819,692 |  | Unchanged |
| [Surrozen Inc (SRZN)](/companies/srzn.md) | COM NEW | $10.0m | 3.2% | 385,178 |  | Unchanged |
| [Surrozen Inc (SRZN)](/companies/srzn.md) | COM NEW | $10.0m | 3.2% | 385,178 |  | Unchanged |
| [Aclaris Therapeutics Inc (ACRS)](/companies/acrs.md) | COM | $9.7m | 3.1% | 1,832,365 |  | Unchanged |
| [Aclaris Therapeutics Inc (ACRS)](/companies/acrs.md) | COM | $9.7m | 3.1% | 1,832,365 |  | Unchanged |
| [Sionna Therapeutics Inc (SION)](/companies/sion.md) | COM | $8.7m | 2.8% | 197,072 |  | Unchanged |
| [Sionna Therapeutics Inc (SION)](/companies/sion.md) | COM | $8.7m | 2.8% | 197,072 |  | Unchanged |
| [Inhibikase Therapeutics Inc (IKT)](/companies/ikt.md) | COM NEW | $7.8m | 2.5% | 3,821,890 |  | Added +1,149,282 |
| [Inhibikase Therapeutics Inc (IKT)](/companies/ikt.md) | COM NEW | $7.8m | 2.5% | 3,821,890 |  | Added +1,149,282 |
| Pharvaris NV | COM | $6.9m | 2.2% | 198,772 |  | Unchanged |
| Pharvaris NV | COM | $6.9m | 2.2% | 198,772 |  | Unchanged |
| [Karyopharm Therapeutics Inc (KPTI)](/companies/kpti.md) | COM NEW | $6.7m | 2.1% | 685,644 |  | New +685,644 |
| [Karyopharm Therapeutics Inc (KPTI)](/companies/kpti.md) | COM NEW | $6.7m | 2.1% | 685,644 |  | New +685,644 |
| [Septerna Inc (SEPN)](/companies/sepn.md) | COM | $6.5m | 2.1% | 194,544 |  | Unchanged |
| [Septerna Inc (SEPN)](/companies/sepn.md) | COM | $6.5m | 2.1% | 194,544 |  | Unchanged |
| Inflarx Nv | COM | $6.5m | 2.1% | 2,897,769 |  | New +2,897,769 |
| Inflarx Nv | COM | $6.5m | 2.1% | 2,897,769 |  | New +2,897,769 |
| Cyclerion Therapeutics Inc | COM | $5.6m | 1.8% | 1,651,350 |  | New +1,651,350 |
| Cyclerion Therapeutics Inc | COM | $5.6m | 1.8% | 1,651,350 |  | New +1,651,350 |
| [Korro Bio Inc (KRRO)](/companies/krro.md) | COM | $5.3m | 1.7% | 405,040 |  | Added +295,664 |
| Uniqure Nv | SHS | $3.7m | 1.2% | 79,407 |  | Reduced −211,702 |
| Uniqure Nv | SHS | $3.7m | 1.2% | 79,407 |  | Reduced −211,702 |
| [LeonaBio Inc (LONA)](/companies/lona.md) | COM | $3.6m | 1.2% | 393,701 |  | Unchanged |
| [LeonaBio Inc (LONA)](/companies/lona.md) | COM | $3.6m | 1.2% | 393,701 |  | Unchanged |
| Damora Therapeutics Inc | COM NEW | $3.6m | 1.2% | 139,000 |  | Unchanged |
| Damora Therapeutics Inc | COM NEW | $3.6m | 1.2% | 139,000 |  | Unchanged |
| [MoonLake Immunotherapeutics (MLTX)](/companies/mltx.md) | CLASS A ORD | $3.4m | 1.1% | 175,734 |  | Unchanged |
| [MoonLake Immunotherapeutics (MLTX)](/companies/mltx.md) | CLASS A ORD | $3.4m | 1.1% | 175,734 |  | Unchanged |
| [Adlai Nortye (ANL)](/companies/anl.md) | SPONSORED ADS | $2.6m | 0.8% | 226,415 |  | New +226,415 |
| [Tyra Biosciences Inc (TYRA)](/companies/tyra.md) | COM | $2.4m | 0.8% | 74,465 |  | Unchanged |
| [Tyra Biosciences Inc (TYRA)](/companies/tyra.md) | COM | $2.4m | 0.8% | 74,465 |  | Unchanged |
| [Nuvectis Pharma Inc (NVCT)](/companies/nvct.md) | COM | $1.8m | 0.6% | 100,000 |  | New +100,000 |
| [Nuvectis Pharma Inc (NVCT)](/companies/nvct.md) | COM | $1.8m | 0.6% | 100,000 |  | New +100,000 |
| Gossamer Bio Inc | COM | $1.8m | 0.6% | 11,149,363 |  | Added +913,070 |
| Gossamer Bio Inc | COM | $1.8m | 0.6% | 11,149,363 |  | Added +913,070 |
| [Milestone Pharmaceuticals Inc (MIST)](/companies/mist.md) | COM | $1.7m | 0.5% | 1,269,237 |  | New +1,269,237 |
| [Milestone Pharmaceuticals Inc (MIST)](/companies/mist.md) | COM | $1.7m | 0.5% | 1,269,237 |  | New +1,269,237 |
| [Atyr Pharma Inc (ATYR)](/companies/atyr.md) | COM NEW | $1.1m | 0.3% | 1,788,167 |  | New +1,788,167 |
| [Atyr Pharma Inc (ATYR)](/companies/atyr.md) | COM NEW | $1.1m | 0.3% | 1,788,167 |  | New +1,788,167 |
| [Instil Bio Inc (TIL)](/companies/til.md) | COM NEW | $765.9k | 0.2% | 99,600 |  | Reduced −83,430 |
| [Instil Bio Inc (TIL)](/companies/til.md) | COM NEW | $765.9k | 0.2% | 99,600 |  | Reduced −83,430 |
| [Tscan Therapeutics Inc (TCRX)](/companies/tcrx.md) | COM | $445.8k | 0.1% | 454,876 |  | New +454,876 |
| [Tscan Therapeutics Inc (TCRX)](/companies/tcrx.md) | COM | $445.8k | 0.1% | 454,876 |  | New +454,876 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [DiaMedica Therapeutics Inc (DMAC)](/companies/dmac.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −62,488 |
| [DiaMedica Therapeutics Inc (DMAC)](/companies/dmac.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −62,488 |
| [Kalaris Therapeutics Inc (KLRS)](/companies/klrs.md) | COM | $0 | 0.0% | 0 |  | Sold out −135,585 |
| [Kalaris Therapeutics Inc (KLRS)](/companies/klrs.md) | COM | $0 | 0.0% | 0 |  | Sold out −135,585 |
| [LONGEVERON INC (LOOP)](/companies/loop.md) | COM | $0 | 0.0% | 0 |  | Sold out −347,539 |
| [Oruka Therapeutics Inc (ORKA)](/companies/orka.md) | COM | $0 | 0.0% | 0 |  | Sold out −118,524 |
| [Oruka Therapeutics Inc (ORKA)](/companies/orka.md) | COM | $0 | 0.0% | 0 |  | Sold out −118,524 |
| [PepGen Inc (PEPG)](/companies/pepg.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,000,000 |
| [PepGen Inc (PEPG)](/companies/pepg.md) | COM | $0 | 0.0% | 0 |  | Sold out −729,961 |
| [Relay Therapeutics Inc (RLAY)](/companies/rlay.md) | COM | $0 | 0.0% | 0 |  | Sold out −901,457 |
| [Relay Therapeutics Inc (RLAY)](/companies/rlay.md) | COM | $0 | 0.0% | 0 |  | Sold out −901,457 |
| [Tenaya Therapeutics Inc (TNYA)](/companies/tnya.md) | COM | $0 | 0.0% | 0 |  | Sold out −2,000,000 |
| [Tenaya Therapeutics Inc (TNYA)](/companies/tnya.md) | COM | $0 | 0.0% | 0 |  | Sold out −2,000,000 |

Source: SEC EDGAR, Form 13F-HR, accession 0002106181-26-000007. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.